Showing results (251-260 of 269) with videos related to

Sort By:
Pageof 27
Arthritis and Rheumatism|May 28, 2010
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registryBenjamin Terrier, Zahir Amoura, Philippe Ravaud, et al.
RMD Open|October 23, 2025
Unravelling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrumKevin Chevalier, Benjamin Thoreau, Marc Michel, et al.
Immunity|April 28, 2022
Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variantAurélien Sokal, Matteo Broketa, Giovanna Barba-Spaeth, et al.
Clinical Rheumatology|March 25, 2020
Analysis of risk factors for complications and adverse obstetrical outcomes in women with Takayasu arteritis: a French retrospective study and literature reviewNoémie Abisror, Arsene Mekinian, Eric Hachulla, et al.
Annals of the Rheumatic Diseases|September 21, 2023
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective studyBerengere Molina, Roberto Padoan, Maria Letizia Urban, et al.
Immunity|August 5, 2023
SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individualsAurélien Sokal, Giovanna Barba-Spaeth, Lise Hunault, et al.
BMJ (Clinical Research Ed.)|May 16, 2020
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care dataMatthieu Mahévas, Viet-Thi Tran, Mathilde Roumier, et al.
American Journal of Hematology|January 8, 2026
Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in FranceGuillaume Moulis, Matthieu Mahévas, Jean-François Viallard, et al.
Medicine|December 27, 2011
IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registryMikael Ebbo, Laurent Daniel, Michel Pavic, et al.
The Lancet. Haematology|December 12, 2018
Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational studyNicolas Delanoy, Jean-Marie Michot, Thibault Comont, et al.
Pageof 27